Opportunity Information: Apply for RFA OD 10 008

  • The National Institutes of Health in the health recovery act sector is offering a public funding opportunity titled "Recovery Act Limited Competition Comparative Effectiveness Research on Upper Endoscopy in Gastroesophageal Reflux Disease, Eradication Methods for Methicillin Resistant Staphylococcus aureus and Dementia Detection and Management Strategies (RC4)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.701 Trans NIH Recovery Act Research Support.
  • This funding opportunity was created on Dec 28, 2009 and posted on Dec 28, 2009.
  • Applicants must submit their applications by Feb 26, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $15,000,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $500,000.00 in funding.
  • Eligible applicants include: State governments Special district governments City or township governments Public and State controlled institutions of higher education Independent school districts Public housing authorities/Indian housing authorities Private institutions of higher education Native American tribal governments (Federally recognized) County governments Small businesses Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification).
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for RFA OD 10 008

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The National Institutes of Health (NIH) released this Recovery Act funding opportunity to jump start preliminary comparative effectiveness research (CER) in a few specific, high priority clinical areas where stronger evidence was considered overdue. The program is funded through the American Recovery and Reinvestment Act of 2009 (ARRA), and it is framed as a limited competition intended to move quickly and generate useful, near term information for patients, clinicians, and health systems. A key point is that NIH is not looking for large, definitive, multi year phase III style trials here. Instead, the agency describes the projects as large pilot or preliminary studies that can test feasibility, refine study designs, generate early comparative results, and set the stage for later, more conclusive CER.

The announcement focuses on three targeted topics: (1) the use of upper endoscopy in gastroesophageal reflux disease (GERD), (2) methods to eradicate methicillin resistant Staphylococcus aureus (MRSA), and (3) strategies for dementia detection and management. Within each topic, the intent is to compare real world alternatives that clinicians and patients actually face, rather than testing an intervention against placebo in an artificial setting. NIH states that the CER definition should follow the Federal Coordinating Council definition (as referenced in the FOA), which generally emphasizes comparing benefits and harms of different interventions and strategies in typical practice to inform decision making.

The funding mechanism is the RC4, an ARRA specific NIH grant mechanism created for Recovery Act research support. Total funding planned under the FOA is $15 million, divided evenly across the three topic areas (about $5 million per topic). NIH anticipated making roughly 4 to 6 awards per topic area in fiscal year 2010, depending on the number of applications received, their quality, and the availability of funds. Individual project budgets are capped at $1.25 million in total costs for the entire project, and the project period cannot exceed three years. There is no cost sharing or matching requirement, which lowers the barrier for organizations that might not have discretionary funds to contribute.

Eligibility is broad and includes many types of U.S. organizations that can conduct applied health research. Eligible applicants listed include state, county, and city or township governments; special district governments; public and state controlled institutions of higher education; private institutions of higher education; independent school districts; public housing authorities and Indian housing authorities; federally recognized tribal governments and other tribal organizations; small businesses and other for profit organizations; and nonprofit organizations (including both 501(c)(3) and certain non 501(c)(3) entities). The FOA also explicitly notes additional eligible groups such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic Serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith based or community based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. This wide eligibility reflects the practical nature of CER, where useful studies often require access to health systems, community settings, or large patient populations rather than only traditional academic laboratories.

In terms of timing and administrative details, the opportunity is listed as a discretionary grant under a health related Recovery Act funding activity category, with CFDA number 93.701 (Trans NIH Recovery Act Research Support). It was posted on December 28, 2009, and the application due date was February 26, 2010, with an archive date of March 29, 2010. The funding opportunity number is RFA OD 10 008, and NIH is the sponsoring agency. Applicants were directed to the full announcement on the NIH grants site for complete requirements and instructions. For technical issues accessing or linking to the announcement, NIH provided an Office of Extramural Research (OER) webmaster contact (FBOWebmaster@OD.NIH.GOV).

Overall, this FOA is best understood as a time limited Recovery Act initiative meant to produce practical, decision relevant evidence in three specific clinical problem areas. It funds well scoped, comparatively oriented studies that can be completed within three years and within a $1.25 million total cost cap, with the expectation that results will help guide future, larger CER investments and improve real world clinical decision making in GERD endoscopy use, MRSA eradication approaches, and dementia detection and management strategies.

Frequently Asked Questions (FAQs)

What is this NIH funding opportunity trying to accomplish?

This Recovery Act funding opportunity is intended to jump start preliminary comparative effectiveness research (CER) in a small number of high priority clinical areas where stronger evidence was considered overdue. The goal is to produce practical, decision-relevant findings for patients, clinicians, and health systems in the near term.

Is NIH looking for large, definitive clinical trials under this FOA?

No. NIH explicitly states it is not seeking large, definitive, multi-year, Phase III-style trials. Instead, projects are expected to function as large pilot or preliminary studies that can test feasibility, refine study designs, generate early comparative results, and prepare the field for later, more conclusive CER.

What clinical topics are supported by this announcement?

The FOA targets three specific topic areas: (1) the use of upper endoscopy in gastroesophageal reflux disease (GERD), (2) methods to eradicate methicillin-resistant Staphylococcus aureus (MRSA), and (3) strategies for dementia detection and management.

What does NIH mean by "comparative effectiveness research" (CER) in this FOA?

NIH indicates that the CER definition should follow the Federal Coordinating Council definition referenced in the FOA. In general terms (as described in the opportunity summary), CER emphasizes comparing benefits and harms of different interventions and strategies in typical practice settings to inform real-world decision making.

Should proposed studies compare interventions to placebo?

The intent is to compare real-world alternatives that clinicians and patients actually face, rather than testing an intervention against placebo in an artificial setting.

What grant mechanism is being used?

The funding mechanism is the RC4, an ARRA-specific NIH grant mechanism created for Recovery Act research support.

How much total funding is planned under this FOA?

Total funding planned is $15 million, divided evenly across the three targeted topic areas (about $5 million per topic).

How many awards does NIH expect to make?

NIH anticipated making roughly 4 to 6 awards per topic area in fiscal year 2010, depending on the number of applications received, the quality of those applications, and the availability of funds.

What is the maximum budget allowed per project?

Individual project budgets are capped at $1.25 million in total costs for the entire project period.

How long can the project period be?

The project period cannot exceed three years.

Is cost sharing or matching required?

No. The FOA states there is no cost sharing or matching requirement.

Who is eligible to apply?

Eligibility is broad and includes many types of U.S. organizations capable of conducting applied health research. Examples listed in the FOA summary include:

  • State, county, city, township, and special district governments
  • Public and state-controlled institutions of higher education
  • Private institutions of higher education
  • Independent school districts
  • Public housing authorities and Indian housing authorities
  • Federally recognized tribal governments and other tribal organizations
  • Small businesses and other for-profit organizations
  • Nonprofit organizations (including 501(c)(3) and certain non-501(c)(3) entities)

Are minority-serving institutions and community-based organizations included in eligibility?

Yes. The FOA summary explicitly notes additional eligible groups, including Alaska Native and Native Hawaiian Serving Institutions, Hispanic Serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and faith-based or community-based organizations.

Are federal agencies and U.S. territories eligible?

Yes. The FOA summary lists eligible federal agencies, regional organizations, and U.S. territories or possessions among the eligible applicant types.

Why is eligibility so broad for this program?

The FOA frames CER as practical, applied research that often requires access to health systems, community settings, and large patient populations, not only traditional academic research environments. The broad eligibility is consistent with that real-world orientation.

What is the CFDA number associated with this opportunity?

The CFDA number is 93.701 (Trans-NIH Recovery Act Research Support).

What is the funding opportunity number (FOA number)?

The funding opportunity number is RFA OD 10 008.

When was this FOA posted and when were applications due?

It was posted on December 28, 2009. The application due date was February 26, 2010.

What is the archive date for this funding opportunity?

The archive date listed is March 29, 2010.

Which agency is sponsoring this opportunity?

The sponsoring agency is the National Institutes of Health (NIH).

Where were applicants directed to find full requirements and instructions?

Applicants were directed to the full announcement on the NIH grants site for complete requirements and instructions.

Who should be contacted for technical issues accessing or linking to the announcement?

For technical issues, NIH provided the Office of Extramural Research (OER) webmaster contact: FBOWebmaster@OD.NIH.GOV.

How should applicants think about the overall purpose and scope of projects funded under this FOA?

This is best understood as a time-limited Recovery Act initiative to produce practical, decision-relevant evidence in three specific clinical problem areas. It supports well-scoped, comparative studies that can be completed within three years and within the $1.25 million total cost cap, with results intended to inform clinical decision making and help guide future, larger CER investments.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health Recovery Act

Next opportunity: Recovery Act Limited Competition NIH Directors Opportunity for Research in Five Thematic Areas (RC4)

Previous opportunity: ARRAOS Recovery Act Limited Competition Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research Pilot Research (RC4)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA OD 10 008

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA OD 10 008) also looked into and applied for these:

Funding Opportunity
Recovery Act Limited Competition NIH Directors Opportunity for Research in Five Thematic Areas (RC4) Apply for RFA OD 10 005

Funding Number: RFA OD 10 005
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: Case Dependent
Recovery Act Limited Competition Methodology Development in Comparative Effectiveness Research (RC4) Apply for RFA OD 10 009

Funding Number: RFA OD 10 009
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: $500,000
Recovery Act Limited Competition Research On Biosamples From Selected Diabetes Clinical Studies (RC4) Apply for RFA OD 10 010

Funding Number: RFA OD 10 010
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: Case Dependent
ARRA OS Recovery Act 2009 Accelerating Adoption of Comparative Effectiveness Research Results by Providers and Patients (R18) Apply for RFA AE 10 001

Funding Number: RFA AE 10 001
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: Case Dependent
Recovery Act Limited Competition Institutional Comparative Effectiveness Research Mentored Career Development Award (KM1) Apply for RFA OD 10 011

Funding Number: RFA OD 10 011
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: Case Dependent
ARRA OS Recovery Act 2009 Limited Competition Enhanced Registries for Quality Improvement and Comparative Effectiveness Research (R01) Apply for RFA HS 10 020

Funding Number: RFA HS 10 020
Agency: Agency for Health Care Research and Quality
Category: Health Recovery Act
Funding Amount: $4,000,000
Recovery Act Limited Competition Framework Programs for Global Health Signature Innovations Initiative (R24) Apply for RFA OD 10 007

Funding Number: RFA OD 10 007
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: $250,000
Recovery Act Limited Competition Program to Enhance NIH supported Global Health Research Involving Human Subjects (S07) Apply for RFA OD 10 006

Funding Number: RFA OD 10 006
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: $50,000
ARRA OS Recovery Act 2009 Limited Competition Accelerating Implementation of Comparative Effectiveness Findings on Clinical and Delivery System Interventions by Leveraging AHRQ Networks (R18) Apply for RFA HS 10 014

Funding Number: RFA HS 10 014
Agency: Agency for Health Care Research and Quality
Category: Health Recovery Act
Funding Amount: $16,660,000
ARRA OS Recovery Act 2009 Limited Competition Comparative Effectiveness Delivery System Evaluation Grants (R01) Apply for RFA HS 10 012

Funding Number: RFA HS 10 012
Agency: Agency for Health Care Research and Quality
Category: Health Recovery Act
Funding Amount: $500,000
ARRA OS Recovery Act 2009 Limited Competition Comparative Effectiveness Delivery System Demonstration Grants (R18) Apply for RFA HS 10 013

Funding Number: RFA HS 10 013
Agency: Agency for Health Care Research and Quality
Category: Health Recovery Act
Funding Amount: Case Dependent
ARRA OS Recovery Act 2009 Limited Competition Enhanced State Data for Analysis and Tracking of Comparative Effectiveness Impact Improved Clinical Content and Race Ethnicity Data (R01) Apply for RFA HS 10 010

Funding Number: RFA HS 10 010
Agency: Agency for Health Care Research and Quality
Category: Health Recovery Act
Funding Amount: Case Dependent
Recovery Act Limited Competition The NIH Directors ARRA Funded Pathfinder Award to Promote Diversity in the Scientific Workforce (DP4) Apply for RFA OD 10 013

Funding Number: RFA OD 10 013
Agency: National Institutes of Health
Category: Health Recovery Act
Funding Amount: $2,000,000
2010 ARRA Prevention and Wellness Leveraging National Organizations Apply for OS PAW 10 001

Funding Number: OS PAW 10 001
Agency: Office of the Assistant Secretary for Health
Category: Health Recovery Act
Funding Amount: $1,500,000
ARRA Training in Primary Care Medicine Interdisciplinary and Interprofessional Joint Graduate Degree Apply for HRSA 10 236

Funding Number: HRSA 10 236
Agency: Health Resources and Services Administration
Category: Health Recovery Act
Funding Amount: Case Dependent
ARRA Training in Primary Care Medicine Physician Assistant Training in Primary Care Apply for HRSA 10 234

Funding Number: HRSA 10 234
Agency: Health Resources and Services Administration
Category: Health Recovery Act
Funding Amount: Case Dependent
ARRA Training in Primary Care Medicine Predoctoral Training in Primary Care Apply for HRSA 10 233

Funding Number: HRSA 10 233
Agency: Health Resources and Services Administration
Category: Health Recovery Act
Funding Amount: Case Dependent
ARRA Training in Primary Care Medicine Physician Faculty Development in Primary Ca Apply for HRSA 10 232

Funding Number: HRSA 10 232
Agency: Health Resources and Services Administration
Category: Health Recovery Act
Funding Amount: Case Dependent
ARRA Training in Primary Care Medicine Administrative Academic Units in Primary Care Apply for HRSA 10 231

Funding Number: HRSA 10 231
Agency: Health Resources and Services Administration
Category: Health Recovery Act
Funding Amount: Case Dependent
American Recovery and Reinvestment Act of 2009, Funding to Beacon Communities Apply for HHS 2010 ONC BC 006

Funding Number: HHS 2010 ONC BC 006
Agency: Office of the National Coordinator
Category: Health Recovery Act
Funding Amount: $18,000,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA OD 10 008", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.